Vis enkel innførsel

dc.contributor.authorKallestad, Håvard
dc.contributor.authorSaksvik, Simen Berg
dc.contributor.authorVedaa, Øystein
dc.contributor.authorLangsrud, Knut
dc.contributor.authorMorken, Gunnar
dc.contributor.authorLydersen, Stian
dc.contributor.authorSimpson, Melanie Rae
dc.contributor.authorDørheim, Signe Karen
dc.contributor.authorHolmøy, Bjørn
dc.contributor.authorGermans Selvik, Sara
dc.contributor.authorHagen, Kristen
dc.contributor.authorStiles, Tore C
dc.contributor.authorHarvey, Allison G.
dc.contributor.authorRitterband, Lee M.
dc.contributor.authorSivertsen, Børge
dc.contributor.authorScott, Janine Linda
dc.date.accessioned2021-10-07T10:42:47Z
dc.date.available2021-10-07T10:42:47Z
dc.date.created2021-07-09T13:43:35Z
dc.date.issued2021
dc.identifier.citationBMJ Open. 2021, 11(6), 1-9.en_US
dc.identifier.issn2044-6055
dc.identifier.urihttps://hdl.handle.net/11250/2788360
dc.description.abstractIntroduction Insomnia is highly prevalent in outpatients receiving treatment for mental disorders. Cognitive–behavioural therapy for insomnia (CBT-I) is a recommended first-line intervention. However, access is limited and most patients with insomnia who are receiving mental healthcare services are treated using medication. This multicentre randomised controlled trial (RCT) examines additional benefits of a digital adaptation of CBT-I (dCBT-I), compared with an online control intervention of patient education about insomnia (PE), in individuals referred to secondary mental health clinics. Methods and analysis A parallel group, superiority RCT with a target sample of 800 participants recruited from treatment waiting lists at Norwegian psychiatric services. Individuals awaiting treatment will receive an invitation to the RCT, with potential participants undertaking online screening and consent procedures. Eligible outpatients will be randomised to dCBT-I or PE in a 1:1 ratio. Assessments will be performed at baseline, 9 weeks after completion of baseline assessments (post-intervention assessment), 33 weeks after baseline (6 months after the post-intervention assessment) and 61 weeks after baseline (12 months after the post-intervention assessment). The primary outcome is between-group difference in insomnia severity 9 weeks after baseline. Secondary outcomes include between-group differences in levels of psychopathology, and measures of health and functioning 9 weeks after baseline. Additionally, we will test between-group differences at 6-month and 12-month follow-up, and examine any negative effects of the intervention, any changes in mental health resource use, and/or in functioning and prescription of medications across the duration of the study. Other exploratory analyses are planned.en_US
dc.language.isoengen_US
dc.publisherBMJ Publishing Group Ltd.en_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleDigital cognitive-behavioural therapy for insomnia compared with digital patient education about insomnia in individuals referred to secondary mental health services in Norway: Protocol for a multicentre randomised controlled trialen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber1-9en_US
dc.source.volume11en_US
dc.source.journalBMJ Openen_US
dc.source.issue6en_US
dc.identifier.doi10.1136/bmjopen-2021-050661
dc.identifier.cristin1921182
dc.source.articlenumbere050661en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal